Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Sales | 59,791 | 111,392 | 104,324 | 91,212 | 83,653 |
| Cost of Goods | N/A | 17,433 | 21,482 | 22,959 | 16,776 |
| Gross Profit | 59,791 | 93,959 | 82,842 | 68,253 | 66,877 |
| Operating Expenses | 63,784 | 102,256 | 91,507 | 96,007 | 102,774 |
| Operating Income | -3,993 | -7,864 | -8,183 | -26,795 | -35,121 |
| Interest Expense | 3,605 | 3,693 | 3,122 | 2,650 | 2,655 |
| Other Income | 5,268 | 5,042 | 4,064 | 3,330 | 2,781 |
| Pre-tax Income | -2,330 | -6,515 | -7,241 | -26,115 | -34,995 |
| Income Tax | 323 | 208 | 118 | 115 | -899 |
| Net Income Continuous | -2,653 | -6,723 | -7,359 | -26,230 | -34,096 |
| Net Income Discontinuous | -87,055 | N/A | N/A | N/A | N/A |
| Net Income | $-89,708 | $-6,723 | $-7,359 | $-26,230 | $-34,096 |
| EPS Basic Total Ops | -0.78 | -0.06 | -0.06 | -0.23 | -0.31 |
| EPS Basic Continuous Ops | -0.02 | -0.06 | -0.06 | -0.23 | -0.31 |
| EPS Basic Discontinuous Ops | -0.76 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.78 | -0.06 | -0.06 | -0.23 | -0.31 |
| EPS Diluted Continuous Ops | -0.02 | -0.06 | -0.06 | -0.23 | -0.31 |
| EPS Diluted Discontinuous Ops | -0.76 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $15,544 | $11,205 | $11,982 | $-7,551 | $-19,564 |